The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders
Abstract
BACKGROUND: The present paper describes a component of a large population cost-effectiveness study that aimed to identify the averted burden and economic efficiency of current and optimal treatment for the major mental disorders. This paper reports on the findings for the anxiety disorders (panic disorder/agoraphobia, social phobia, generalized anxiety disorder, post-traumatic stress disorder and obsessive compulsive disorder). METHOD: Outcome was calculated as averted 'years lived with disability' (YLD), a population summary measure of disability burden. Costs were the direct health care costs in 1997-8 Australian dollars. The cost per YLD averted (efficiency) was calculated for those already in contact with the health system for a mental health problem (current care) and for a hypothetical optimal care package of evidence-based treatment for this same group. Data sources included the Australian National Survey of Mental Health and Well-being and published treatment effects and unit costs. RESULTS: Current coverage was around 40% for most disorders with the exception of social phobia at 21%. Receipt of interventions consistent with evidence-based care ranged from 32% of those in contact with services for social phobia to 64% for post-traumatic stress disorder. The cost of this care was estimated at dollar 400 million, resulting in a cost per YLD averted ranging from dollar 7761 for generalized anxiety disorder to dollar 34 389 for panic/agoraphobia. Under optimal care, costs remained similar but health gains were increased substantially, reducing the cost per YLD to < dollar 20 000 for all disorders. CONCLUSIONS: Evidence-based care for anxiety disorders would produce greater population health gain at a similar cost to that of current care, resulting in a substantial increase in the cost-effectiveness of treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although effective behavioral and pharmacological interventions exist, many people struggling with SAD experience ongoing symptoms following treatment (16, 167) or do not present for treatment (5) indicating room for innovation in SAD treatment strategies.”
Citations
Cites
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Laupacis, A., Feeny, D. H., Detsky, A. S., & Tugwell, P. (1992) · Europe PMC (PubMed Central) · Cited by 1,581
The economic burden of anxiety disorders in the 1990s
Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R., Davidson, J. R. T., Ballenger, J. C., & Fyer, A. J. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0702 · Cited by 1,242 · cited 4×
“Greenberg et al. (1999) similarly reported that more than half of the annual costs of anxiety disorders in the United States were attributable to non-psychiatric medical treatment costs, a situation they argued could be avoided with increased recognition, appropriate referral and effective…”
BackgroundInfluentialThe quality of care for depressive and anxiety disorders in the United States
Young, A. S., Klap, R., Sherbourne, C. D., & Wells, K. B. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.1.55 · Cited by 1,061
Quality of Life in Individuals With Anxiety Disorders
Mendlowicz, M. V., & Stein, M. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.669 · Cited by 955
Andrews, G., Henderson, S., & Hall, W. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.2.145 · Cited by 933
Willingness to Pay for a Quality-adjusted Life Year: In Search of a Standard
Hirth, R. A., Chernew, M. E., Miller, E., Fendrick, A. M., & Weissert, W. G. (2000) · Medical Decision Making · doi:10.1177/0272989x0002000310 · Cited by 850
Adequacy of Treatment for Serious Mental Illness in the United States
Wang, P. S., Demler, O., & Kessler, R. C. (2002) · American Journal of Public Health · doi:10.2105/ajph.92.1.92 · Cited by 581
A meta-analysis of treatment outcome for panic disorder
Gould, R. A., Ott, M. W., & Pollack, M. H. (1995) · Clinical Psychology Review · doi:10.1016/0272-7358(95)00048-8 · Cited by 520
(1998) · PubMed · Cited by 460
Shortfall in mental health service utilisation
Andrews, G., Issakidis, C., & Carter, G. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.5.417 · Cited by 420 · cited 13×
“Although the majority of published unit costs represented the exact and ‘real ’ costs to the government of each particular unit of treatment, the NSMHWB did not contain information on the length or nature of consultations.”
BackgroundMethodInfluentialPsychological and Pharmacological Treatments of Social Phobia: A Meta-Analysis
Fedoroff, I. C., & Taylor, S. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200106000-00011 · Cited by 396 · cited 2×
“Several systematic reviews have found that ESs for treatment of anxiety disorders are higher if derived from clinician rated than from self-report measures (e.g. Fedoroff & Taylor, 2001).”
BackgroundGould, R. A., Otto, M. W., Pollack, M. H., & Yap, L. (1997) · Behavior Therapy · doi:10.1016/s0005-7894(97)80048-2 · Cited by 352
A meta-analysis of self-help treatment approaches
Gould, R. A., & Clum, G. A. (1993) · Clinical Psychology Review · doi:10.1016/0272-7358(93)90039-o · Cited by 337
The social costs of anxiety disorders
Leon, A. C., Portera, L., & Weissman, M. M. (1995) · British Journal of Psychiatry · doi:10.1192/s0007125000293355 · Cited by 335 · cited 2×
“2001a), associated with significant individual suffering (Mendlowicz & Stein, 2000) and substantial societal burden (Leon et al. 1995).”
BackgroundLost productivity among full‐time workers with mental disorders
Lim, D., Sanderson, K. A., & Andrews, G. (2000) · The Journal of Mental Health Policy and Economics · doi:10.1002/mhp.93 · Cited by 266
Health economics and cost implications of anxiety and other mental disorders in the United States
Rice, D. P., & Miller, L. S. (1998) · The British Journal of Psychiatry · doi:10.1192/s0007125000293458 · Cited by 261
Impact of Generalized Social Anxiety Disorder in Managed Care
Katzelnick, D. J., Kobak, K. A., DeLeire, T., Henk, H. J., Greist, J. H., Davidson, J. R. T., Schneier, F. R., Stein, M. B., & Helstad, C. P. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.1999 · Cited by 261
Depression, anxiety, and social disability show synchrony of change in primary care patients.
Ormel, J., Korff, M. V., van den Brink, W., Katon, W. J., Brilman, E. I., & Oldehinkel, A. J. (1993) · American Journal of Public Health · doi:10.2105/ajph.83.3.385 · Cited by 252
Unequal access and unmet need: neurotic disorders and the use of primary care services
BEBBINGTON, P. E., MELTZER, H., BRUGHA, T. S., FARRELL, M., JENKINS, R., CERESA, C., & LEWIS, G. (2000) · Psychological Medicine · doi:10.1017/s0033291799002950 · Cited by 229 · cited 4×
“Data from the UK and the USA have indicated similar low rates of mental health treatment by those with anxiety disorders who consulted health professionals (Bebbington et al. 2000b ; Wang et al. 2002).”
BackgroundInfluentialPolicy Implications for Implementing Evidence-Based Practices
Goldman, H. H., Ganju, V. K., Drake, R. E., Gorman, P., Hogan, M. F., Hyde, P. S., & Morgan, O. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.12.1591 · Cited by 195
Neurotic disorders and the receipt of psychiatric treatment
Bebbington, P., Brugha, T. S., Meltzer, H., Jenkins, R., Ceresa, C., Farrell, M., & Lewis, G. (2000) · Psychological Medicine · doi:10.1017/s0033291799002974 · Cited by 166
The National Psychiatric Morbidity Surveys of Great Britain – strategy and methods
JENKINS, R., BEBBINGTON, P., BRUGHA, T., FARRELL, M., GILL, B., LEWIS, G., MELTZER, H., & PETTICREW, M. (1997) · Psychological Medicine · doi:10.1017/s003329179700531x · Cited by 153
Service utilisation for anxiety in an Australian community sample
Issakidis, C., & Andrews, G. (2002) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270200009 · Cited by 118
Self-citationCost-Outcome Methods for Mental Health
Hargreaves, W. A., Shumway, M., Hu, T.-W., & Cuffel, B. (1997) · Cited by 101
Hatziandreu, E. J., Brown, R. E., Revicki, D. A., Turner, R. R., Martindale, J. J., Levine, S., & Siegel, J. E. (1994) · PharmacoEconomics · doi:10.2165/00019053-199405030-00008 · Cited by 85
Davidson, J. R. T. (2000) · PubMed · Cited by 70
Determinants of Pharmacologic Treatment Failure in Panic Disorder
Cowley, D. S., Ha, E. H., & Roy‐Byrne, P. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n1208 · Cited by 60
Current Status of Psychotherapeutic Interventions for Social Phobia
Heimberg, R. G. (2001) · The Primary Care Companion to The Journal of Clinical Psychiatry · Cited by 55
Treatment of generalized social phobia: Results at long-term follow-up
Scholing, A., & Emmelkamp, P. M. G. (1996) · Behaviour Research and Therapy · doi:10.1016/0005-7967(96)00010-1 · Cited by 54
Using the effect size to model change in preference values from descriptive health status
Sanderson, K. A., Andrews, G., Corry, J., & Lapsley, H. (2004) · Quality of Life Research · doi:10.1023/b:qure.0000037482.92757.82 · Cited by 48
Long-Term Outcome of Panic Disorder and Social Phobia
Hunt, C. J., & Andrews, G. (1998) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(98)00023-1 · Cited by 41
Chancellor, J. V. M., Coyle, D., & Mf, D. (1997) · Quality of Life Research · doi:10.1023/a:1026494218030 · Cited by 36
Hollander, E., & Cohen, L. J. (1994) · PubMed · Cited by 35
Therapeutic strategies for the patient with treatment-resistant anxiety.
Coplan, J. D., Tiffon, L., & Gorman, J. M. (1993) · PubMed · Cited by 19
Treatment resistance in anxiety disorders.
Davies, R. D., Dubovsky, S. L., Gabbert, S. L., & Chapman, M. (2000) · PubMed · Cited by 7
Economic costs of anxiety disorders
DuPont, R. L., Rice, D. P., Miller, L. S., Shiraki, S. S., Rowland, C. R., & Harwood, H. J. (1996) · Anxiety · doi:10.1002/(sici)1522-7154(1996)2:4
Cited by
Sorted by citations
Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection
Kroenke, K., Spitzer, R. L., Williams, J. B. W., Monahan, P. O., & Löwe, B. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00004 · Cited by 4,741
“While antidepressants are certainly effective for all 4 anxiety disorders, evidence-based psychotherapies, such as cognitive–behavioral therapy, are equally or more effective, are considered first-line treatment in some (but not all) clinical guidelines, and should strongly be considered if initial treatment with medi…”
BackgroundKroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.03.006 · Cited by 4,057
“The four most common anxiety disorders (excluding simple phobias which seldom present clinically) are generalized anxiety disorder, panic disorder, social anxiety disorder and posttraumatic stress disorder (PTSD) [128].”
BackgroundInfluentialA Systematic Review of the Prevalence of Schizophrenia
Saha, S., Chant, D., Welham, J., & McGrath, J. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020141 · Cited by 2,168
Stein, M. B., & Stein, D. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60488-2 · Cited by 1,137
The global burden of anxiety disorders in 2010
Baxter, A. J., Vos, T., Scott, K. M., Ferrari, A. J., & Whiteford, H. A. (2014) · Psychological Medicine · doi:10.1017/s0033291713003243 · Cited by 768
“This is relevant to policy makers in terms of reducing population burden as current treatments are shown to be more cost-effective for mild and moderate cases than for severe cases (Issakidis et al. 2004).”
Background
Metadata
- Authors
- ISSAKIDIS, C., SANDERSON, K., CORRY, J., ANDREWS, G., & LAPSLEY, H.
- Affiliations
- UNSW Sydney (AU)
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2004-01
- Volume
- 34
- Issue
- 1
- Pages
- 19-35
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2036167557
- Cited by
- 110
- References
- 37
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 3 · 2021: 10 · 2020: 1 · 2019: 3 · 2018: 5 · 2017: 1 · 2016: 5 · 2015: 3 · 2014: 8 · 2013: 4 · 2012: 9
- FWCI
- 26.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychological Medicine (publishedVersion)
- PubMed (publishedVersion)
- eCite Digital Repository (University of Tasmania) (submittedVersion)
- Figshare (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- anxiety disorders, cost-effectiveness, evidence-based treatment, years lived with disability, disability burden, generalized anxiety disorder, panic disorder, agoraphobia, social anxiety disorder, post-traumatic stress disorder, obsessive-compulsive disorder, treatment costs
- MeSH terms
- Anxiety Disorders, Australia, Cost-Benefit Analysis, Humans, Mental Health Services, Monte Carlo Method, Anti-Anxiety Agents, Cognitive Behavioral Therapy, Health Care Costs, Models, Econometric, Cost of Illness, Quality-Adjusted Life Years, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
